Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients

Serum Resistin, Cardiovascular Disease and All-Cause Mortality in Patients with Type 2 Diabetes

(2013) Claudia Menzaghi et al.   PLoS One

Plasma resistin, adiponectin, and risk of incident atrial fibrillation: The Framingham Offspring Study

(2011) Michiel Rienstra et al.   AMERICAN HEART JOURNAL

Adiponectin moderates the relationship between adiposity and leptin in adolescents regardless of gender or race

(2011) Vanessa Bundy et al.   JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Adiponectin in Chronic Kidney Disease: A Complex and Context Sensitive Clinical Situation

(2011) Peter Stenvinkel   JOURNAL OF RENAL NUTRITION

Associations between leptin and the leptin / adiponectin ratio and incident Type 2 diabetes in middle-aged men and women: results from the MONICA / KORA Augsburg Study 1984-2002

(2010) B. Thorand et al.   DIABETIC MEDICINE

Association of Resistin With Heart Failure and Mortality in Patients With Stable Coronary Heart Disease: Data From the Heart and Soul Study

(2010) Mary H. Zhang et al.   JOURNAL OF CARDIAC FAILURE

Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients

(2010) C. Zoccali et al.   JOURNAL OF INTERNAL MEDICINE

The effect of joint exposures: examining the presence of interaction

(2009) Renée de Mutsert et al.   KIDNEY INTERNATIONAL

Plasma adiponectin and resistin levels as predictors of mortality in patients with acute myocardial infarction: data from infarction prognosis study registry

(2008) Sang-Hak Lee et al.   CORONARY ARTERY DISEASE